Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group
Open Access
- 12 December 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 2912
- https://doi.org/10.3389/fimmu.2018.02912
Abstract
Patients with inborn errors of immunity or DNA repair defects are at significant risk of developing malignancy and this complication of their underlying condition represents a substantial cause of morbidity and mortality. Whilst this risk is increasingly well-recognized, our understanding of the causative mechanisms remains incomplete. Diagnosing cancer is challenging in the presence of underlying co-morbidities and frequently other inflammatory and lymphoproliferative processes. We lack a structured approach to management despite recognizing the competing challenges of poor response to therapy and increased risk of toxicity. Finally, clinicians need guidance on how to screen for malignancy in many of these predisposing immunodeficiencies. In order to begin to address these challenges, we brought together representatives of European Immunology and Pediatric Haemato-Oncology to define the current state of our knowledge and identify priorities for clinical and research development. We propose key developmental priorities which our two communities will need to work together to address, collaborating with colleagues around the world.Keywords
This publication has 61 references indexed in Scilit:
- Malignancies are the major cause of death in patients with adult onset common variable immunodeficiencyBlood, 2012
- Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27Haematologica, 2012
- Morbidity and mortality in common variable immune deficiency over 4 decadesBlood, 2012
- Why do viruses cause cancer? Highlights of the first century of human tumour virologyNature Reviews Cancer, 2010
- Immune surveillance of tumorsJCI Insight, 2007
- Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiencyThe Journal of Experimental Medicine, 2005
- Hodgkin disease in ataxia‐telangiectasia patients with poor outcomesMedical and Pediatric Oncology, 2003
- The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosisBlood, 2001
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- PROSPECTIVE STUDY OF CANCER IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIAThe Lancet, 1985